Here you will find the highlights of the TCT Conference 2017, held on October 29-31 and November 1-2 in the city of Denver, Colorado (USA). If you cannot view the articles, click here
The SOURCE 3 Confirms the Good Outcomes of the SAPIEN 3 at One Year Followup
Transcatheter aortic valve replacement (TAVR) was developed as a strategy to treat non-surgical aortic stenosis, and was later expanded to elderly patients at intermediate risk, because of increased operator experience (overcoming the learning curve) and improved devices. The present study presents the one year outcomes of the SOURCE 3 trial, the multicenter European registry of the...
2.0-mm DES for Very Small Vessels: Are They Viable?
The reference vessel diameter is a fundamental factor for restenosis after coronary angioplasty even with drug-eluting stents. The smallest sized stents available are 2.25 mm in diameter, but even smaller vessels can be symptomatic. This was a prospective multicenter trial of the Resolute Onyx 2.0-mm zotarolimus-eluting stent. The primary endpoint was target lesion failure. Read also: “Effects...
SOLACI Symposium at TCT 2017
Next Sunday, October 29, one of the most important cardiology meetings starts in Denver, Colorado: the TCT annual congress. In this context, SOLACI is taking part in two significant events, with some of its most renowned members. Calendar the following sessions: TCT Regional Session: Latin America Intervention at TCT Sunday, October 29, 2017 1:00...
Effects of Cerebral Radiation on Interventional Cardiologists
In recent years, there has been a growing concern about the occupational hazard for interventional cardiologists who have high and unprecedented levels of ionizing radiation exposure. microRNAs are a class of short and highly conserved non-coding RNA molecules (about 22 nucleotides) that become altered (dysregulated) in many diseases. Read also: “Nearly half of interventional cardiologists may...
Congratulations to the winners of Colombia Sessions!
The past 05 and 06 of October, the 34th SOLACI Regional Sessions took place. During the event, there were two important contests: Imaging and Young Cardiologists. Dr. Gustavo Andres Ortega Ramírez, from Pontificia Bolivariana University (CardioVID Clinic) was awarded 1st price for the Clinical Studies for Young Interventionists contest, sponsored by ABBOTT Vascular. We also...
REPRISE III: Need for Pacemaker and Paravalvular Leak with Lotus
A recent presentation at London Valves took a closer look at the REPRISE III trial as regards two points that generated much discussion, such as need for a pacemaker and paravalvular leak. REPRISE III had previously demonstrated that the Lotus is noninferior to first-generation CoreValve and Evolut R in terms of safety. Additionally, it proved to be superior...
Small Annulus: Should We Start Choosing the Valve?
Courtesy of Dr. Carlos Fava. A small annulus in patients with Severe Aortic Stenosis is a real challenge, since it is associated with post-surgical prosthesis patient mismatch (PPM), which negatively affects prosthesis duration and evolution. TAVR has become a good alternative strategy, with better hemodynamic profile and lower PPM incidence in this group. The present study included 246...
TCT 2017 Congress Coming Soon
The TCT 2017 Congress will take place from October 29th to November 2nd in Denver, Colorado. Check all the event-related news, the guest list, the scientific activities, etc., by clicking We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.
Multivessel Disease and Severe Carotid Stenosis: How to Proceed
Myocardial revascularization surgery (CABG) is the most frequent of all cardiovascular surgeries and is still the gold standard to treat multivessel disease. Between 6 and 8% of these patients present concomitant carotid stenosis and it is associated with increased peri and post procedural stroke rates during and after surgery. To prevent carotid stenosis, either PCI or endarterectomy...